About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Gimap5tm1Wlr
targeted mutation 1, Hartmut Weiler
MGI:3828512
Summary 1 genotype
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Gimap5tm1Wlr/Gimap5tm1Wlr either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr MGI:3828851


Genotype
MGI:3828851
hm1
Allelic
Composition
Gimap5tm1Wlr/Gimap5tm1Wlr
Genetic
Background
either: B6.129-Gimap5tm1Wlr or C.129-Gimap5tm1Wlr
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gimap5tm1Wlr mutation (0 available); any Gimap5 mutation (13 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
mortality/aging
• reduced life span
• deaths as early as 5 weeks
• substantial mortality between 10 and 20 weeks
• only one of 35 survived beyond 42 weeks

hematopoietic system
• hematocrit mildly reduced
• heterogeneity of red blood cell size
• mild thrombocytopenia in younger but not in older mice
• deficient mauration of CD8+ T cells in the thymus
• 3.8 fold increase in granulocytes
• 1.6 fold reduction of peripheral lymphocytes
• reduced B220 and CD19+ B cells in the spleen, pancreatic and inguinal lymph nodes
• numbers significantly reduced in bone marrow and the spleen
• 9 fold reduction in T cell number in the spleen, pancreatic and inguinal lymph nodes
• 2 fold reduction in CD4+ cells in the spleen, pancreatic and inguinal lymph nodes
• 8 fold increase in apoptotic cells in the spleen, pancreatic and inguinal lymph nodes
• 20 fold reduction in CD8+ cells in the spleen, pancreatic and inguinal lymph nodes
• 4 fold increase in apoptotic cells in the spleen, pancreatic and inguinal lymph nodes
• numbers significantly reduced in bone marrow and the spleen
• abnormalities in spleen morphology are less pronounced than those seen in the liver
• splenic cellularity reduced 2 fold

immune system
• deficient mauration of CD8+ T cells in the thymus
• 3.8 fold increase in granulocytes
• 1.6 fold reduction of peripheral lymphocytes
• reduced B220 and CD19+ B cells in the spleen, pancreatic and inguinal lymph nodes
• numbers significantly reduced in bone marrow and the spleen
• 9 fold reduction in T cell number in the spleen, pancreatic and inguinal lymph nodes
• 2 fold reduction in CD4+ cells in the spleen, pancreatic and inguinal lymph nodes
• 8 fold increase in apoptotic cells in the spleen, pancreatic and inguinal lymph nodes
• 20 fold reduction in CD8+ cells in the spleen, pancreatic and inguinal lymph nodes
• 4 fold increase in apoptotic cells in the spleen, pancreatic and inguinal lymph nodes
• numbers significantly reduced in bone marrow and the spleen
• abnormalities in spleen morphology are less pronounced than those seen in the liver
• splenic cellularity reduced 2 fold
• pancreatic lymph nodes are small and grayish at 10-16 weeks of age
• bone marrow cells are deficient in repopulating lethally irradiated hosts

liver/biliary system
N
• livers are normal at 2 weeks
• small foci of hematopoietic cells can be found at two weeks
• mononuclear and polymorphonuclear cells are abundant
• hematopoietic precursors are present, particularly those for granulocytes
• parenchymal collapse
• hepatocellular degeneration and necrosis
• scarred, retracted, and hyperemic hepatic tissue
• hepatocellular degeneration and necrosis
• livers develop pale nodules





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory